Abstract
Purpose
Symptom control and improved quality of life (QOL) are primary goals of treatment in palliative oncology. The present study assessed and compared patient demographics, baseline Karnofsky Performance Status (KPS) and QOL using the QLQ-C15-PAL questionnaire prior to palliative radiotherapy (RT) for bone, brain, or lung disease. Few studies have used this questionnaire, an abbreviated version that was developed by the European Organization for Research and Treatment of Cancer specifically for patients with advanced cancer to decrease the burden of completing the longer, more time-consuming QLQ-C30.
Methods
Patients referred to an outpatient palliative RT clinic completed QLQ-C15-PAL questionnaires prior to palliative RT for bone, brain, or lung cancer sites. The associations between baseline QLQ-C15-PAL functional/symptom scales, patient demographics, and clinical variables including KPS were explored.
Results
When data from all 369 patients were analyzed, higher KPS scores correlated significantly with better overall QOL and higher physical and emotional functioning. The QLQ-C15-PAL provided more detailed information regarding how symptom burden varied depending on disease site. Patients with bone metastases had worse QLQ-C15-PAL scores for pain, while those with brain and lung disease had worse scores for fatigue. Other health-related QOL scores measured by the QLQ-C15-PAL varied as a function of age and gender.
Conclusion
As the QLQ-C15-PAL provides detailed and often critical information regarding symptom burden, it may eventually be recognized as a universal core questionnaire to assess QOL in this patient population with advanced cancer while relieving the survey burden.
Similar content being viewed by others
References
Kirkbride P, Tannock IF (2008) Trials in palliative treatment—have the goal posts been moved? Lancet Oncol 9:186–187
Movsas B (2003) Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol 13:235–247
Spilker B, Revicki A (1996) Taxonomy of quality of life. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials. Lippincott Williams & Wilkins, Philadelphia, p 1259
Chow E, Wu JS, Hoskin P et al (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 67:275–280
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
EORTC group for research into Quality of Life (2010). European organization for research and treatment of cancer. http://groups.eortc.be/qol/. Accessed 15 August 2010
Wong J, Hird A, Kirou-Mauro A, Napolskikh J, Chow E (2008) Quality of life in brain metastases radiation trials: a literature review. Curr Oncol 15:25–45
Yaneva MP, Semerdjieva MA (2006) Assessment of the effect of palliative radiotherapy for cancer patients with intercranial metastases using EORTC-QOL-C30 questionnaire. Folia Med 48:23–29
Roos DE, Wirth A, Burmeister BH et al (2006) Whole brain irradiation following surgery or radiosurgery for soliatary brain metastases: mature results of a prematurely closed randomized trans-Tasman radiation oncology group trial (TROG98.05). Radiother Oncol 80:318–322
Gerrard GE, Prestwich RJ, Edwards A et al (2003) Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin Oncol 15:422–428
Mauer ME, Taphoorn MJ, Bottomley A et al (2007) Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol 25:5731–5737
Kramer JA, Curran D, Piccart M et al (2000) Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 36:1498–1506
Groenvold M, Petersen MA, Aaronson NK et al (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42:55–64
Steinmann D, Schäfer C, van Oorschot B et al (2009) Effects of radiotherapy for brain metastases on quality of life (QoL) prospective pilot study of the DEGRO QoL Working Party. Strahlenther Onkol 185:190–197
Suárez-Del-Real Y, Allende-Pérez S, Alférez-Mancera A, et al. (2011) Validation of the Mexican–Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care. Psychooncology (in press)
Fayers PM, Aaronson N, Bjordal K et al (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organization for Research and Treatment of Cancer, Brussels
Shapiro SS, Wilk MB (1965) An analysis of variance test for normality (complete samples). Biometrika 52(3–4):591–611
Echteld MA, Deliens L, Onwuteaka-Philipsen B, Klein M, van der Wal G (2006) EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advaced cancer? Palliat Med 20:1–2
Groenvold M, Petersen MA, Aaronson NK et al (2006) EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? Palliat Med 20:59–61
Chow E, Bottomley A (2009) Understanding the EORTC QLQ-BM22, the module for patients with bone metastases. Expert Rev Pharmacoecon Outcomes Res 9:461–465
Chow E, Hird A, Velikova G et al (2009) The European organization for research and treatment of cancer quality of life questionnaire for patients with bonemetastases: the EORTC QLQ-BM22. Eur J Cancer 45:1146–1152
Rosemann T, Hermann K, Miksch A, Engeser P, Szecsenui J (2007) The PAMINO-project: evaluating a primary care-based educational program to improve the quality of life of palliative patients. BMC Palliat Care 6:5
Cheung WY, Le LW, Gaglieses L, Zimmermann C (2011) Age and gender differences in symptom intensity and symptom clusters amoung patients with metastatic cancer. Support Care Cancer 19:417–423
Acknowledgments
This project is generously supported by the Michael and Karyn Goldstein Cancer Research Fund. We thank Stacy Yuen and Kristina Facchini for their secretarial assistance.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caissie, A., Culleton, S., Nguyen, J. et al. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy. Support Care Cancer 20, 841–848 (2012). https://doi.org/10.1007/s00520-011-1160-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1160-6